23Jun
M&A Litigation Continued: Simon v. Taubman and Seller Remedies in the Age of COVID-19
Since the start of the COVID-19 pandemic, several buyers in M&A transactions have sought to avoid closing on a transaction alleging that the seller experienced a material adverse effect (MAE) or breached interim operating covenants between signing and closing. A MAE is typically defined in the definitive agreement and can be a heavily negotiated point and interim operating covenants have historically been tied to operating in the ordinary course......
By:
White and Williams LLP
Related
A court in Florida has declined to expand the remedies available under a claim for benefits due unde...
Read More >
Over the last decade the use of R&W insurance in merger and acquisition transactions has grown expon...
Read More >
What Happened: On 10 September 2019, European Commission President-elect Ursula von der Leyen nomin...
Read More >
July 4, 2019, is the 10th anniversary of the adoption of the Law of the Republic of Kazakhstan “On ...
Read More >
Summary- The US Court of Appeals for the 4th Circuit held that a subrogation waiver provision in a ...
Read More >
Continuing our annual tradition, we have compiled our top developments and headlines for 2019 & 2020...
Read More >